| | | | | |
RNAC Cartesian Therapeutics, Inc. Common Stock | €8,5754 | -1,96 % | €272,43M | €53,02K | |
FUND Sprott Focus Trust, Inc. | €9,2364 | -0,09 % | €272,27M | €19,38K | |
FATE Fate Therapeutics, Inc. | €2,1760 | -1,36 % | €272,14M | €1,35M | |
NMRA Neumora Therapeutics, Inc. Common Stock | €1,2704 | -5,13 % | €271,97M | €458,26K | |
GALT Galectin Therapeutics Inc. | €3,5667 | +0,12 % | €271,82M | €296,34K | |
NREF NexPoint Real Estate Finance, Inc. | €14,9190 | +1,11 % | €271,80M | €42,43K | |
POLE Andretti Acquisition Corp. II Class A Ordinary Shares | €9,2192 | -0,28 % | €271,55M | €927,93 | |
PSBD Palmer Square Capital BDC Inc. | €8,8158 | -0,29 % | €271,52M | €32,85K | |
| €2,6825 | -3,55 % | €271,33M | €560,10K | |
| €5,6054 | -0,91 % | €271,15M | €8,55K | |
SMTI Sanara MedTech Inc. Common Stock | €29,6835 | -0,20 % | €270,90M | €137,94K | |
MLP Maui Land & Pineapple Co. | €13,5971 | -0,94 % | €270,87M | €8,85K | |
AFB Alliance National Municipal Income Fund, Inc. | €9,3737 | +0,05 % | €270,68M | €39,91K | |
| €36,5335 | -0,38 % | €270,65M | €16,45K | |
TVA Texas Ventures Acquisition III Corp Class A Ordinary Share | €9,0561 | +0,05 % | €270,65M | €43,01K | |
